# Biased GRK Signaling Via β2-Adrenergic Receptors in Human Skeletal Muscle

> **NCT07421024** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Morten Hostrup, PhD** · enrollment: 10 (estimated)

## Conditions studied

- Overweight and Obesity

## Interventions

- **DRUG:** ATR-258

## Key facts

- **NCT ID:** NCT07421024
- **Lead sponsor:** Morten Hostrup, PhD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02-20
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-02-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07421024

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07421024, "Biased GRK Signaling Via β2-Adrenergic Receptors in Human Skeletal Muscle". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT07421024. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*